Accendra Health (ACH) Cost of Revenue (2009 - 2026)

Accendra Health (ACH) has reported Cost of Revenue for 18 consecutive years, with $349.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cost of Revenue fell 1.38% year-over-year to $349.8 million; the TTM figure through Mar 2026 stood at $1.4 billion (up 63.54% YoY), while the FY2025 annual figure was $1.5 billion, up 18.23% from the prior year.
• Cost of Revenue retreated to $349.8 million in Q1 2026 per ACH's latest filing, from $385.7 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.1 billion in Q4 2022 and bottomed at -$4.9 billion in Q4 2023.
• Historically, Cost of Revenue has averaged $804.9 million across 5 years, with a median of $385.7 million in 2025.
• Annual changes were most pronounced in 2023 — Cost of Revenue slumped 330.87% — and 2025, when it jumped 5828.04%.
• Accendra Health's Cost of Revenue stood at $2.1 billion in 2022, then slumped by 330.87% to -$4.9 billion in 2023, then jumped by 104.2% to $208.0 million in 2024, then surged by 85.45% to $385.7 million in 2025, then slipped by 9.32% to $349.8 million in 2026.
• Business Quant data shows ACH's Cost of Revenue at $349.8 million in Q1 2026, $385.7 million in Q4 2025, and $375.1 million in Q3 2025.